Sign In
Buy AB
$37.35
+0.190 (+0.511%)
At Close: Jul 13, 2026
AB Announces June 30, 2026 Assets Under Management
04:05pm, Monday, 13'th Jul 2026
NASHVILLE, Tenn., July 13, 2026 /PRNewswire/ -- AllianceBernstein L.P.
AB to Report Second Quarter 2026 Results on July 28, 2026
11:27am, Monday, 06'th Jul 2026
NASHVILLE, Tenn., July 6, 2026 /PRNewswire/ -- AllianceBernstein L.P.
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
04:09pm, Monday, 22'nd Jun 2026
NEW YORK, June 22, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc.[NYSE: AWF] (the "Fund") today released its monthly portfolio update as of May 31, 2026. AllianceBernstein Global
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
04:06pm, Monday, 22'nd Jun 2026
NEW YORK, June 22, 2026 /PRNewswire/ -- AllianceBernstein National Municipal Income Fund, Inc. [NYSE: AFB] (the "Fund") today released its monthly portfolio update as of May 31, 2026. AllianceBernstei
Forget Big Tech: Nancy Pelosi Just Poured Millions Into This Under-the-Radar Dividend Stock
08:45am, Thursday, 18'th Jun 2026
Nancy Pelosi filed a Periodic Transaction Report earlier this year, disclosing a purchase of AllianceBernstein (NYSE: AB) units in the $1,000,001 to $5,000,000 range, with a transaction date of Januar
AB Akola Group notification on transactions in the Company's securities by the person discharging managerial responsibilities
01:40am, Thursday, 18'th Jun 2026
AB Akola Group, ISIN code LT0000128092, (hereinafter - the Company), has received a notification from the person discharging managerial responsibilities regarding the transactions in the Company's sec
COMMUNIQUÉ DE PRESSE LE BREVET D'AB SCIENCE CONCERNANT LE MASITINIB DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE HORMONO-RÉSISTANT A ÉTÉ OFFICIELLEMENT DÉLIVRÉ AUX ÉTATS-UNIS AVEC
PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2042 THIS POSITIVE DECISIO
PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2042 THIS POSITIVE DECISIO
AB Announces May 31, 2026 Assets Under Management
04:05pm, Wednesday, 10'th Jun 2026
NASHVILLE, Tenn., June 10, 2026 /PRNewswire/ -- AllianceBernstein L.P.
New Strong Sell Stocks for May 28th
07:25am, Thursday, 28'th May 2026
BKR, ASH and AB have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2026.
COMMUNIQUÉ DE PRESSE À LA SUITE DE LA PUBLICATION DES RÉSULTATS DE L'EXERCICE 2025 ET DE LA SOUSCRIPTION D'UNE ASSURANCE POUR LES ESSAIS CLINIQUES, MAXIM GROUP RÉITÈRE SA RECOMMANDATION D'ACHAT S
AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
12:06pm, Monday, 25'th May 2026
PRESS RELEASE FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE'S STOCK WITH A TARGET PRICE OF EUR 4. 0
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
04:06pm, Friday, 22'nd May 2026
NEW YORK, May 22, 2026 /PRNewswire/ -- AllianceBernstein National Municipal Income Fund, Inc. [NYSE: AFB] (the "Fund") today released its monthly portfolio update as of April 30, 2026. AllianceBernst
AllianceBernstein Global High Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
04:06pm, Friday, 22'nd May 2026
NEW YORK, May 22, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. [NYSE: AWF] (the "Fund") today released its monthly portfolio update as of April 30, 2026. AllianceBernstein Glob
